Yuanxin Liang Selected Research

Yuanxin Liang Research Topics

5	Neoplasms (Cancer) 06/2019 - 01/2014
4	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2014
1	Granuloma 12/2021
1	Inflammation (Inflammations) 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2017
1	Pneumonia (Pneumonitis) 01/2016
1	Type 1C Charcot-Marie-Tooth disease 07/2015
1	Adenocarcinoma of Lung 03/2015
1	Carcinogenesis 01/2014
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Osteoarthritis 04/2010
1	Pain (Aches) 04/2010
1	Osteopetrosis 04/2010
1	Heart Diseases (Heart Disease) 09/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2009
1	Cardiomegaly (Heart Hypertrophy) 09/2009

2	Azacitidine (5 Azacytidine)FDA Link 01/2016 - 01/2014
2	AerosolsIBA 01/2016 - 01/2014
2	Phosphotransferases (Kinase)IBA 07/2015 - 05/2014
1	AntralIBA 12/2021
1	SynaptophysinIBA 06/2019
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	ChemokinesIBA 07/2015
1	CytokinesIBA 07/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2015
1	Aurora KinasesIBA 05/2014
1	Cell Cycle ProteinsIBA 05/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2013
1	Angiotensin IIIBA 09/2009
1	3,3',4',5,7-pentamethylquercetinIBA 09/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2009
1	QuercetinIBA 09/2009

3	Therapeutics 03/2015 - 01/2014
1	Mammaplasty (Breast Reconstruction) 01/2019
1	Intravenous Administration 12/2017
1	Aftercare (After-Treatment) 01/2016
1	Transplantation 01/2013
1	Hip Replacement Arthroplasty (Total Hip Replacement) 04/2010
1	Arthroplasty 04/2010
1	Activities of Daily Living (ADL) 04/2010